We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
(+14%)
Cap. Flow
+$908M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$85M |
| 2 |
Abbott
ABT
|
+$72M |
| 3 |
NVIDIA
NVDA
|
+$60.9M |
| 4 |
Teradyne
TER
|
+$52.2M |
| 5 |
Legend Biotech
LEGN
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$98.7M |
| 2 |
Texas Instruments
TXN
|
+$95.4M |
| 3 |
Global Payments
GPN
|
+$54.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$49.4M |
| 5 |
KLA
KLAC
|
+$49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.26% |
| 2 | Technology | 25.67% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 5.47% |
| 5 | Consumer Staples | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cisco
CSCO
$458B
| $17.3M | 0.28% |
+317,831
| New | +$17.8M |
|
102
MacroGenics
MGNX
$238M
| $17.3M | 0.28% |
825,669
+580,073
| +236% | +$14M |
|
|
AVDL
103
DELISTED
Avadel Pharmaceuticals
AVDL
| $16.9M | 0.28% |
1,727,060
+1,494,523
| +643% | +$11.8M |
|
104
ICU Medical
ICUI
$4.35B
| $16.5M | 0.27% |
70,611
+24,419
| +53% | +$5.12M |
|
|
AVLR
105
DELISTED
Avalara, Inc.
AVLR
| $16.4M | 0.27% |
+93,754
| New | +$16.1M |
|
106
Cirrus Logic
CRUS
$6.37B
| $15.9M | 0.26% |
193,448
-93,289
| -33% | -$7.76M |
|
107
Nerdy
NRDY
$108M
| $15.8M | 0.26% |
1,586,326
-207,333
| -12% | -$2.09M |
|
108
IBM
IBM
$215B
| $15.7M | 0.26% |
+118,267
| New | +$15.8M |
|
|
HOLX
109
DELISTED
Hologic
HOLX
| $15.6M | 0.26% |
211,890
+132,441
| +167% | +$9.93M |
|
110
Planet Labs
PL
$7.65B
| $15.5M | 0.25% |
1,564,961
-152,244
| -9% | -$1.51M |
|
111
PayPal
PYPL
$49.3B
| $15.3M | 0.25% |
+58,701
| New | +$16.7M |
|
|
INFO
112
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $15.1M | 0.25% |
+129,449
| New | +$15.3M |
|
113
Biogen
BIIB
$29.7B
| $14.8M | 0.24% |
52,418
-21,039
| -29% | -$6.9M |
|
|
NAPA
114
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $14.8M | 0.24% |
645,918
-928
| -0.1% | -$20.2K |
|
|
CNTA
115
DELISTED
Centessa Pharmaceuticals
CNTA
| $14.7M | 0.24% |
882,813
+60,295
| +7% | +$1.25M |
|
116
Teleflex
TFX
$6.18B
| $14.7M | 0.24% |
39,000
-105,441
| -73% | -$41.1M |
|
117
Theravance Biopharma
TBPH
$874M
| $14.6M | 0.24% |
1,979,130
+1,604,218
| +428% | +$17.9M |
|
118
Vertex Pharmaceuticals
VRTX
$120B
| $14.6M | 0.24% |
80,487
-83,577
| -51% | -$16.3M |
|
|
VISN
119
Vistance Networks Inc
VISN
$2.69B
| $14.5M | 0.24% |
+1,067,174
| New | +$18.3M |
|
120
Automatic Data Processing
ADP
$108B
| $14.5M | 0.24% |
+72,317
| New | +$14.9M |
|
|
TXNM
121
TXNM Energy Inc
TXNM
$6.38B
| $14.3M | 0.23% |
+290,021
| New | +$14.2M |
|
122
Dell
DELL
$278B
| $13.7M | 0.22% |
+260,312
| New | +$13M |
|
|
KSU
123
DELISTED
Kansas City Southern
KSU
| $13.7M | 0.22% |
+50,631
| New | +$14.1M |
|
124
Knowles
KN
$3.19B
| $13.6M | 0.22% |
727,110
+59,622
| +9% | +$1.17M |
|
125
DexCom
DXCM
$32.8B
| $13.6M | 0.22% |
+99,556
| New | +$12.6M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.
- Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
- Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
- Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
- Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
- Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
- Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.
Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.